Skip to main content
Clinical Trials/IRCT2015022321211N1
IRCT2015022321211N1
Completed
未知

Comparison of treatment outcomes between endoscopic injection of new bulking agent of Vantris® and open surgery of Gil-vernet in 1-10 year-aged children with primary vesicoureteral reflux(VUR)

Vice Chancellor Of Research Of Tabriz University Of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Vesicouretral reflux.
Sponsor
Vice Chancellor Of Research Of Tabriz University Of Medical Sciences
Enrollment
100
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor Of Research Of Tabriz University Of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Iinclusion criteriae: 1\)1\-10 years of old ; 2\) II to IV grade VURs, as defined below: a) Symptomatic UTIs(such as fever,dysuria,poor feeding, FTT); New renal scarring despite of antibiotic prophylaxis; bilateral VUR; Intolerance to prophylactic antibiotics; parent tendency to surgical repair. Exclusion criteriae: 1\)Grades I and V ; 2\) previously open or endoscopic surgeries on bladder or ureters ; 3\) Anantomic malformations of urinary tract such as obstructive disorders or complete duplication of pyelocaliceal system ; 4\)suspicion to or confirmed voiding disorder : a. presence of related clinical findings including abnormal neurologic exam or elimination disorder(instinal and urinary, with together); b.VCUG or ultrasonographic abnormalities such as bladder wall abnormalities or diverticuli ortrabeculation or decreased vesical capacity ; 5\)Neurogenic bladder

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials